Form 8-K - Current report:
SEC Accession No. 0001193125-18-078331
Filing Date
2018-03-12
Accepted
2018-03-12 08:10:09
Documents
52
Period of Report
2018-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d540276d8k.htm 8-K 16830
2 EX-99.1 d540276dex991.htm EX-99.1 76168
3 EX-99.2 d540276dex992.htm EX-99.2 43474
4 GRAPHIC g540276ex99_2s10g1.jpg GRAPHIC 219904
5 GRAPHIC g540276ex99_2s11g1.jpg GRAPHIC 167630
6 GRAPHIC g540276ex99_2s12g1.jpg GRAPHIC 97313
7 GRAPHIC g540276ex99_2s13g1.jpg GRAPHIC 104579
8 GRAPHIC g540276ex99_2s14g1.jpg GRAPHIC 256428
9 GRAPHIC g540276ex99_2s15g1.jpg GRAPHIC 226173
10 GRAPHIC g540276ex99_2s16g1.jpg GRAPHIC 196702
11 GRAPHIC g540276ex99_2s17g1.jpg GRAPHIC 223652
12 GRAPHIC g540276ex99_2s18g1.jpg GRAPHIC 131273
13 GRAPHIC g540276ex99_2s19g1.jpg GRAPHIC 190501
14 GRAPHIC g540276ex99_2s1g1.jpg GRAPHIC 272193
15 GRAPHIC g540276ex99_2s20g1.jpg GRAPHIC 115187
16 GRAPHIC g540276ex99_2s21g1.jpg GRAPHIC 238988
17 GRAPHIC g540276ex99_2s22g1.jpg GRAPHIC 167318
18 GRAPHIC g540276ex99_2s23g1.jpg GRAPHIC 196844
19 GRAPHIC g540276ex99_2s24g1.jpg GRAPHIC 163529
20 GRAPHIC g540276ex99_2s25g1.jpg GRAPHIC 233228
21 GRAPHIC g540276ex99_2s26g1.jpg GRAPHIC 175249
22 GRAPHIC g540276ex99_2s27g1.jpg GRAPHIC 151081
23 GRAPHIC g540276ex99_2s28g1.jpg GRAPHIC 171711
24 GRAPHIC g540276ex99_2s29g1.jpg GRAPHIC 129692
25 GRAPHIC g540276ex99_2s2g1.jpg GRAPHIC 406973
26 GRAPHIC g540276ex99_2s30g1.jpg GRAPHIC 203612
27 GRAPHIC g540276ex99_2s31g1.jpg GRAPHIC 200310
28 GRAPHIC g540276ex99_2s32g1.jpg GRAPHIC 209398
29 GRAPHIC g540276ex99_2s33g1.jpg GRAPHIC 183013
30 GRAPHIC g540276ex99_2s34g1.jpg GRAPHIC 179590
31 GRAPHIC g540276ex99_2s35g1.jpg GRAPHIC 111997
32 GRAPHIC g540276ex99_2s36g1.jpg GRAPHIC 189097
33 GRAPHIC g540276ex99_2s37g1.jpg GRAPHIC 93431
34 GRAPHIC g540276ex99_2s38g1.jpg GRAPHIC 132590
35 GRAPHIC g540276ex99_2s39g1.jpg GRAPHIC 205331
36 GRAPHIC g540276ex99_2s3g1.jpg GRAPHIC 270278
37 GRAPHIC g540276ex99_2s40g1.jpg GRAPHIC 172842
38 GRAPHIC g540276ex99_2s41g1.jpg GRAPHIC 168144
39 GRAPHIC g540276ex99_2s42g1.jpg GRAPHIC 159987
40 GRAPHIC g540276ex99_2s43g1.jpg GRAPHIC 198060
41 GRAPHIC g540276ex99_2s44g1.jpg GRAPHIC 221707
42 GRAPHIC g540276ex99_2s45g1.jpg GRAPHIC 190613
43 GRAPHIC g540276ex99_2s46g1.jpg GRAPHIC 179774
44 GRAPHIC g540276ex99_2s47g1.jpg GRAPHIC 211504
45 GRAPHIC g540276ex99_2s48g1.jpg GRAPHIC 266566
46 GRAPHIC g540276ex99_2s4g1.jpg GRAPHIC 142787
47 GRAPHIC g540276ex99_2s5g1.jpg GRAPHIC 250221
48 GRAPHIC g540276ex99_2s6g1.jpg GRAPHIC 129435
49 GRAPHIC g540276ex99_2s7g1.jpg GRAPHIC 177079
50 GRAPHIC g540276ex99_2s8g1.jpg GRAPHIC 207501
51 GRAPHIC g540276ex99_2s9g1.jpg GRAPHIC 247610
52 GRAPHIC g540276g0310033636647.jpg GRAPHIC 5494
  Complete submission text file 0001193125-18-078331.txt   12739368
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 18682111
SIC: 2834 Pharmaceutical Preparations